SB21-123 Summary

• Authorizes Colorado to expand its existing Canadian prescription drug importation program to include suppliers from nations other than Canada, contingent on federal legislation permitting such imports.

• Requires federal authorization through amendments to 21 U.S.C. Section 384 or other congressional legislation before the state department may import drugs from non-Canadian sources.

• Mandates that foreign suppliers be appropriately licensed, provide cost savings, and operate in nations approved by the U.S. Secretary of Health and Human Services.

• Requires the state department to submit evidence to legislative committees demonstrating that exporting nations' regulatory systems for drug supply chain security, manufacturing, labeling, and tracking are as stringent as FDA standards.

• Mandates the executive director provide 30 days' notice to legislative leadership and relevant health committees before expanding the program to non-Canadian suppliers.